Ma X, Vacek I, Sun A
Department of Physiology, University of Toronto, Ontario, Canada.
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(1):43-69. doi: 10.3109/10731199409117399.
Alginate-poly-l-lysine-alginate (APA) microcapsules have proven effective in protecting enclosed live cells from immune rejection following transplantation into experimental animals, thereby eliminating the need for immunosuppressive therapy. However, in order for the capsules to remain intact for extended periods in vivo, the thickness of the membrane material must be optimized. In this study, the membrane thickness was examined as an indicator of membrane strength and measured under different reaction conditions. The thickness was found to increase 1) from 4.6 microns to 6.6 microns with an increase in the concentration of sodium alginate from 1.25 (w/v) to 2.0% (w.v); 2) from 4.2 microns to 6.2 microns with an increase in the concentration of the calcium solution from 20 mM to 100mM; 3) from 3.9 microns to 10.3 microns with an increase in the concentration of poly-l-lysine (PLL) from 0.02% (w/v) to 0.08% (w/v); and 4) from 2.3 microns to 7.4 microns with an increase in the reaction time with the PLL from two to seven minutes. On the other hand, membrane thickness decreased 1) from 9.8 microns to 8.6 microns with an increase of the pH in the PLL solution from 5.8 to 9.2; 2) from 13.2m to 5.8 microns with an increase in the molecular weight of PLL from 14,000 to 57,000; 3) from 8.4 microns to 6.0 microns with an increase in the treatment time with 0.9 (w/v) NaCl solution from zero to fifteen minutes and; 4) from 7.5 microns to 6.1 microns with an increase in the treatment time of the second sodium alginate coating from zero to ten minutes. Membrane thickness was inversely proportional to capsule volume expansion during membrane synthesis. By replacing calcium chloride by calcium lactate and eliminating the use of CHES in the construction of capsule membranes, we improved the strength and biocompatibility of our capsules, as evidenced by marked improvements in the survival rates of diabetic mice treated with islet transplants enclosed in the new capsules. These results indicate that it is possible to obtain optimal membrane thickness for a given purpose by creating specific reaction conditions under which membranes are synthesized.
藻酸盐-聚-L-赖氨酸-藻酸盐(APA)微胶囊已被证明在将活细胞移植到实验动物体内后,能有效保护其免受免疫排斥,从而无需进行免疫抑制治疗。然而,为了使微胶囊在体内长时间保持完整,必须优化膜材料的厚度。在本研究中,将膜厚度作为膜强度的指标进行检测,并在不同反应条件下进行测量。结果发现,随着藻酸钠浓度从1.25%(w/v)增加到2.0%(w/v),膜厚度从4.6微米增加到6.6微米;随着钙溶液浓度从20 mM增加到100 mM,膜厚度从4.2微米增加到6.2微米;随着聚-L-赖氨酸(PLL)浓度从0.02%(w/v)增加到0.08%(w/v),膜厚度从3.9微米增加到10.3微米;随着与PLL的反应时间从两分钟增加到七分钟,膜厚度从2.3微米增加到7.4微米。另一方面,随着PLL溶液的pH从5.8增加到9.2,膜厚度从9.8微米减少到8.6微米;随着PLL分子量从14,000增加到57,000,膜厚度从13.2微米减少到5.8微米;随着0.9%(w/v)NaCl溶液处理时间从零增加到15分钟,膜厚度从8.4微米减少到6.0微米;随着第二次藻酸钠包衣处理时间从零增加到10分钟,膜厚度从7.5微米减少到6.1微米。膜厚度与膜合成过程中胶囊体积膨胀成反比。通过用乳酸钙替代氯化钙并在胶囊膜构建中不使用CHES,我们提高了胶囊的强度和生物相容性,新胶囊包裹的胰岛移植治疗的糖尿病小鼠存活率显著提高就证明了这一点。这些结果表明,通过创造特定的膜合成反应条件,可以针对特定目的获得最佳膜厚度。